You are on page 1of 16

ADRENERGIC AGONIST

Persiapan CBT September 2020


Bimo Kusumo Bhirowo
Aktivasi ALPHA-1 RECEPTORS
1. Mata

2. Blood Vessel
KONTRAKSI 3. Uterus
SMOOTH MUSCLE 4. Gut

5. Genitourinary
Bronkokonstriksi
Menghambat sekresi insulin
Lipolisis
Morgan & Mikhail’s
Clinical Anesthesiology 6th Edition
ALPHA-2 RECEPTORS

1. Sedasi
Aktivasi 2. Mengurangi sympathetic
outflow
3. Analgesik

Morgan & Mikhail’s


Clinical Anesthesiology 6th Edition
BETA-1 RECEPTORS

INOTROPIK
Aktivasi CHRONOTROPIC
DROMOTROPIC
LUSITROPIC
Morgan & Mikhail’s
Clinical Anesthesiology 6th Edition
Aktivasi BETA-2 RECEPTORS

Relaksasi Glikogenolisis
SMOOTH MUSCLE Gluconeogenesis
Insulin release
Bronkodilatasi
Vasodilatasi
Lipolisis
Relaksasi uterus Morgan & Mikhail’s
Clinical Anesthesiology 6th Edition
Morgan & Mikhail’s
Clinical Anesthesiology 6th Edition
Stoelting’s
Pharmacology & Physiology 5th Edition
Morgan & Mikhail’s
Clinical Anesthesiology 6th Edition
Morgan & Mikhail’s
Clinical Anesthesiology 6th Edition
Norepinephrine
Koroner?
Arteri &
Vena

Hipoperfusi

Preload?

Stoelting’s
Pharmacology & Physiology 5th Edition
Dopamine

/m nt
Low Dose c g/ kg
0,5 - 3m

/ m nt
c g /k g
inotrope 10 m
3- PVR

/m nt
g/k g
vasokonstriksi >1 0 mc

Stoelting’s
Pharmacology & Physiology 5th Edition
Dobutamine

ta s i
<5mcg/kg/mnt d il a
s o
Va

5-20mcg/kg/mnt

Stoelting’s
Pharmacology & Physiology 5th Edition
Ephedrine
Direct &
Indirect

Pada kehamilan?
Anti emetic
I M
/ kg
mg
0, 5
Stoelting’s
Pharmacology & Physiology 5th Edition
Vasopressin
Receptor?

Konservasi air

GI Tract V1 V2
koagulasi
Hem
VWD
A

Goodman & Gilman’s 13th Edition


The Pharmacological Basis of Therapeutics
Dexmedetomidin
Alpha2 agonis
Dose 1mcg/kg/10mnt
0,2-0,7mcg/kg/jam
Hypo atau Hyper?

Goodman & Gilman’s 13th Edition


The Pharmacological Basis of Therapeutics
T K
E A
R S
I I
M H
A

You might also like